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Clostridium indolis is an anaerobic spore-forming Gram-positive bacillus belonging to the 23 
Clostridium saccharolyticum group. Its clinical significance in human remains poorly known. 24 
We describe the first case of osteitis related to C. indolis, identified by MALDI-TOF mass 25 
spectrometry and provide a literature review of human infections related to C. 26 
saccharolyticum group species. 27 
In august 2014, a 37 years-old woman was admitted to the surgical intensive care unit of our 28 
tertiary care center, because of an open Cauchoix III fracture of left tibia and fibula with skin 29 
damages after a motorcycle injury. On admission, the patient was intubated and ventilated. 30 
Body temperature was 36°C.Heart rate and blood pressure were normal. Ionogram, blood 31 
cells count and C-reactive protein (CRP) were all within normal range whereas serum 32 
creatinine phosphokinase (CPK) level was increased to 697 UI/L secondary to muscular lysis.  33 
She underwent an urgent surgery consisting in a tibial-fibular osteosynthesis performed by a 34 
multidisciplinary surgical critical care team involving orthopedic, vascular and plastic 35 
surgeon. In early 2015, she presented a subcutaneous collection located close to orthopedic 36 
screws. This process has grown chronically and was well tolerated during 4 months. On 15 37 
June 2015, she was readmitted because of an acute purulent discharge from this collection that 38 
started 4 days before.  Her body temperature was normal. Laboratory investigations revealed 39 
inflammation markers such as slightly elevated CRP (7.5 mg/L) and moderate neutrophil 40 
polynucleosis (7.9 G/L). The orthopedic treatment consisted in the removal of two screws and 41 
washing. Five bacteriological specimens (screws and collection) were sampled as 42 
recommended by the Société de Pathologie Infectieuse de Langue Française (SPILF) and sent 43 
to our microbiology laboratory for analysis. All samples grew with Enterobacter cloacae (on 44 
all media seeded: 5 out of 5) displaying wild type antibiotic susceptibility pattern to beta-45 
lactams. On the basis of these results and according to the recommendations of SPILF for 46 
osteo-articular infections on osteosynthesis material, a six-weeks antibiotic course of Intra-47 
Venous (IV) cefepime (2g t.i.d) associated with ciprofloxacin IV (400 mg b.i.d) was initiated. 48 
One week later, a new intervention was performed to remove the intramedullary nail materiel. 49 
Four surgical samples (3 soft tissues and 1 bone) were sent to our laboratory. Bacteriological 50 
analysis retrieved E. cloacae displaying cephalosporinase hyperproduction phenotype from all 51 
biological samples (4 out of 4). At the end of July 2015, 4 weeks after the beginning of 52 
antibiotherapy, she underwent a surgical revision with medial fibula transport and an Ilizarov 53 
external fixator was set because of tibial pseudarthrosis. A total of 3 surgical specimens were 54 
sampled (2 soft tissues and one bone). Cultures on Columbia agar plates supplemented with 5 55 
% sheep blood (Oxoid, Dardilly, France) incubated both under anaerobic and aerobic 56 
atmosphere, and cultures on chocolate agar plates (Oxoid, Dardilly, France) incubated under 57 
5% CO2 remained sterile after 96 hours. Culture was positive on Rosenow (Biorad, Marnes-58 
la-Coquette, France) enriched liquid medium after 2 weeks of incubation. Gram staining 59 
showed large spore-forming Gram-variable bacilli. Subculture performed on blood agar plates 60 
under anaerobic conditions grew with medium size mucoid colonies surrounded by a single 61 
zone of beta-hemolysis (two out of three samples). MALDI-TOF mass spectrometry (MS) 62 
performed directly on the colonies identified Clostridium indolis (Log score value of 2.19 63 
matching Clostridium indolis reference strain DSM755T; MALDI Biotyper v2.3). This 64 
identification was confirmed by the National Reference Center of Anaerobic Bacteria and 65 
Botulism (Institut Pasteur, Paris, France)  by 16S rDNA gene sequencing using forward 66 
AAGGAGGTGATCCAGCCGCA and reverse primers AGAGTTTGATCATGGCTCAG, 67 
(99,6% of identity with the sequence of Clostridium indolis type strain DSM755T, GenBank 68 
accession number Y18184) (Strain 570.15, see figure  for phylogenetic analysis) [1–5]. 69 
Antimicrobial susceptibility testing was performed on the isolated strain using E-test strips 70 
(bioMérieux, Marcy-l’Etoile, France), with a 1 McFarland suspension, on Brucella agar plate 71 
supplemented with vitamin K (1 mg/L) and 5% sheep blood that were incubated under 72 
anaerobic atmosphere as recommended by the CASFM 2013. The Minimal Inhibitory 73 
Concentrations (MICs) were read following the CASFM 2013 interpretative standard for 74 
anaerobes (see table1). The antibiotic treatment was changed to oral metronidazole (500 mg 75 
t.i.d) for a total duration of four weeks. Biological markers of inflammation returned normal 76 
at 4 weeks (CRP 4.1 mg/L and normal neutrophils count 2.6 G/L). In February 2016, the 77 
patient reported no painful phenomenon and clinical examination showed clean scars and 78 
body temperature was normal. CRP was negative. Radiological control did not show signs of 79 
osteitis.    80 
Clostridium species are spore forming Gram-positive or Gram-variable anaerobic bacilli that 81 
are ubiquitous in the environment. Some species are part of human digestive microbiota. 82 
Clostridium species like Clostridium difficile, Clostridium perfringens and Clostridium tetani 83 
are well known for their involvement in human infections mostly related to the production of 84 
specific toxins. Clostridium species can also be associated with post-traumatic infections [6] 85 
and only few species among the genus  Clostridium are involved in osteo-articular infections 86 
[7–11]. Interestingly, C. indolis, which belongs to the C. saccharolyticum group along with 87 
Clostridium sphenoides, Clostridium celerecrescens, Clostridium methoxybenzovorans and 88 
Desulfotomaculum guttoideum, has never been reported in any human infection so far. 89 
C.indolis  was isolated only once from a blood culture of a patient presenting without sepsis 90 
syndrome [12]. Furthermore, the clinical significance of C. saccharolyticum species group in 91 
human is not well established. Only 4 cases of infections due to C. sphenoides were reported 92 
(2 gastro-intestinal infections, one bacteremia and one osteomyelitis) [13–16]. Three cases of 93 
C. celerecrescens infections were also described including an osteomyelitis, an abscess 94 
secondary to an open fracture and a post traumatic wound infection [7,8,17] (see table 2 for 95 
details). Here we report the first case of osteitis related to C. indolis identified by MALDI-96 
TOF MS using Biotyper database. The recent spread of new identification tools in routine 97 
such as MALDI-TOF MS allows an accurate identification of bacterial species that were 98 
previously underestimated. Nevertheless, there is only one reference spectrum of C. indolis, 99 
C. sphenoides and C. celerecrescens included in the Bruker database (Biotyper v2.3) and 100 
there is still no reference for C. methoxybenzovorans and D. guttoideum. These limits may 101 
lead to an underestimation of these species. Hopefully, new reference spectra will be soon 102 
included in the upcoming databases. In this study, we further attempted to identify the patient 103 
strain (Strain 570.15) using Rapid ID 32A strips (BioMérieux, Marcy-l’E   l , F   c ) that is 104 
still widely used in routine microbiological diagnosis. The test misidentified the strain as C. 105 
clostridioforme with an acceptable significance (biochemical API profile: 45362000, 99,4% 106 
T=0.77) except for a positive reaction for indole production. Interestingly, Bouvet et al. 107 
reported the misidentification of C. celerecrescens as C. clostridioforme using RAPID ID 108 
32A strips [17]. This type of mistakes pinpoints the need to integrate new strains to refine 109 
biochemical databases. In order to help identifying these phylogenetically related anaerobic 110 
species in routine diagnosis, and waiting for enlarged databases, we provide a summary of the 111 
main biochemical characteristics of C. saccharolyticum species group in the table 3. 112 
Concerning the clinical presentation, the patient was successfully treated by metronidazole, 113 
which is active on C. indolis, and follow-up consultation at six months after the last surgery 114 
reported no physical, biological or radiological signs of infection. Of note, bacteriological 115 
samples obtained after the first orthopedic surgery were positive to E. cloacae in 116 
monobacterial culture, and only four weeks after an appropriate antibiotic treatment with 117 
cefepime and ciprofloxacin targeting E. cloacae, C. indolis was isolated in culture. The strains 118 
showed high resistance level to cefepime and ciprofloxacin with MICs values of 256 mg/L 119 
and 32 mg/L, respectively. Interestingly, the literature review reported high rates of 120 
Clostridium sp. susceptible to moxifloxacin, from 69% to 79% [18,19]. This data suggests 121 
that, in our case, the resistance of the strain to quinolones was probably acquired under 122 
antibiotic pressure. This could be explained by the pre-existence of C. indolis in the wound 123 
and selection of resistant mutants after the first course of antibiotics.  Indeed, even if we did 124 
not detect C. indolis in the first samples as co-pathogen, it seems very likely that it has been 125 
overgrown by E. cloacae. In addition, Clostridium species are environmental organisms, 126 
considered as soil saprophytes, or are part of normal human intestinal flora [20]. Almost all 127 
anaerobic osteomyelitis occur by direct extension from an adjacent focus of infection and are 128 
rarely due to bacteremia [21]. These data along with the absence of other positive 129 
bacteriological samples and/or digestive symptoms, suggest that this post-traumatic chronic 130 
osteitis occurred after a telluric contamination. Furthermore, the prolonged contact between 131 
the open wound and the ground after the accident can easily explain this mode of infection.  132 
In conclusion, we described here the first case of osteitis due to Clostridium indolis in an 133 
immunocompetent patient successfully treated by a multidisciplinary medico-surgical 134 
approach while this bacterium was previously considered as non-pathogenic. Data concerning 135 
C. saccharolyticum species group are still lacking in the literature. Hopefully, the spread of 136 
new identification tools in bacterial routine identification such as MALDI-TOF MS and 16S 137 
rDNA sequencing would help its diagnosis and provide a better understanding of its clinical 138 
significance in human infections. 139 
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